251
Views
0
CrossRef citations to date
0
Altmetric
Nephrology

Clinical and economic outcomes of assigning percutaneous coronary intervention patients to contrast-sparing strategies based on the predicted risk of contrast-induced acute kidney injury

Pages 663-670 | Received 30 May 2023, Accepted 20 Mar 2024, Published online: 22 Apr 2024

References

  • Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936. doi: 10.1053/ajkd.2002.32766.
  • Abellás-Sequeiros RA, Raposeiras-Roubín S, Abu-Assi E, et al. Mehran contrast nephropathy risk score: is it still useful 10 years later? J Cardiol. 2016;67(3):262–267. doi: 10.1016/j.jjcc.2015.05.007.
  • Araujo GN, Wainstein MV, McCabe JM, et al. Comparison of two risk models in predicting the incidence of contrast-induced nephropathy after percutaneous coronary intervention. J Interv Cardiol. 2016;29(5):447–453. doi: 10.1111/joic.12315.
  • Aubry P, Brillet G, Catella L, et al. Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures. BMC Nephrol. 2016;17(1):167. doi: 10.1186/s12882-016-0385-5.
  • Chong E, Poh KK, Liang S, et al. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Ann Acad Med Singap. 2010;39(5):374–380. doi: 10.47102/annals-acadmedsg.V39N5p374.
  • Chou RH, Huang PH, Hsu CY, et al. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions. J Formos Med Assoc. 2016;115(7):501–509. doi: 10.1016/j.jfma.2015.12.008.
  • Lian D, Liu Y, Liu YH, et al. Pre-Procedural risk score of contrast-induced nephropathy in elderly patients undergoing elective coronary angiography. Int Heart J. 2017;58(2):197–204. doi: 10.1536/ihj.16-129.
  • Caruso M, Balasus F, Incalcaterra E, et al. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. Intern Med. 2011;50(9):983–989. doi: 10.2169/internalmedicine.50.4976.
  • Mehran R, Faggioni M, Chandrasekhar J, et al. Effect of a contrast modulation system on contrast media use and the rate of acute kidney injury after coronary angiography. JACC Cardiovasc Interv. 2018;11(16):1601–1610. doi: 10.1016/j.jcin.2018.04.007.
  • Almendarez M, Gurm HS, Mariani J Jr, et al. Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention. JACC Cardiovasc Interv. 2019;12(19):1877–1888. doi: 10.1016/j.jcin.2019.04.055.
  • Azzalini L, Laricchia A, Regazzoli D, et al. Ultra-Low contrast percutaneous coronary intervention to minimize the risk for contrast-induced acute kidney injury in patients with severe chronic kidney disease. J Invasive Cardiol. 2019;31(6):176–182.
  • Allen DW, Ma B, Leung KC, et al. Risk prediction models for contrast-induced acute kidney injury accompanying cardiac catheterization: systematic review and meta-analysis. Can J Cardiol. 2017;33(6):724–736. doi: 10.1016/j.cjca.2017.01.018.
  • Silver SA, Shah PM, Chertow GM, et al. Risk prediction models for contrast induced nephropathy: systematic review. BMJ. 2015;351:h4395. doi: 10.1136/bmj.h4395.
  • Duan C, Cao Y, Liu Y, et al. A new preprocedure risk score for predicting contrast-induced acute kidney injury. Can J Cardiol. 2017;33(6):714–723. doi: 10.1016/j.cjca.2017.01.015.
  • Gurm HS, Seth M, Kooiman J, et al. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2013;61(22):2242–2248. doi: 10.1016/j.jacc.2013.03.026.
  • Mo H, Ye F, Chen D, et al. A predictive model based on a new CI-AKI definition to predict contrast induced nephropathy in patients with coronary artery disease with relatively normal renal function. Front Cardiovasc Med. 2021;8:762576. doi: 10.3389/fcvm.2021.762576.
  • Malik AO, Amin A, Kennedy K, et al. Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention. Am Heart J. 2021;234:51–59. doi: 10.1016/j.ahj.2020.12.013.
  • Amin AP, Crimmins-Reda P, Miller S, et al. Reducing acute kidney injury and costs of percutaneous coronary intervention by patient-centered, evidence-based contrast use. Circ Cardiovasc Qual Outcomes. 2019;12(3):e004961.
  • World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. 2nd ed. Geneva: World Health Organization; 2004.
  • US Bureau of Labor Statistics. Measuring price change in the CPI: medical care. 2022; [accessed 2022 Apr 15]. Available from: https://www.bls.gov/cpi/factsheets/medical-care.htm
  • Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi: 10.1097/00005650-199801000-00004.
  • Steyerberg EW, Pencina MJ, Lingsma HF, et al. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration. Eur J Clin Invest. 2012;42(2):216–228. doi: 10.1111/j.1365-2362.2011.02562.x.
  • van der Molen AJ, Reimer P, Dekkers IA, et al. Post-contrast acute kidney injury - part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR contrast medium safety committee guidelines. Eur Radiol. 2018;28(7):2845–2855. doi: 10.1007/s00330-017-5246-5.